In acute lymphoblastic leukemia, oral squamous cell carcinoma, ovarian cancer, and hepatocellular carcinoma, HDAC6 acts as a tumor inducer: its overexpression is correlated with a more advanced stage and increased tumor aggressiveness18–21. Here, HDAC6 is linked to ovarian carcinoma.